Our products and services include:
Analyzing and Forecasting the Commercial Outlook for Drugs on the Market and in Research and Development
Pharmacor, Decision Resources' flagship advisory service, assesses the overall clinical and commercial environment for drug therapies within a disease indication.
The Ultimate Analysis of New and Growing Pharmaceutical Markets
Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis.
Empowering Decision Makers with Robust Data and Analysis
DecisionBase combines market forecasts with clinical and commercial end points to assess market share projections in 35 indications.
Customizable Epidemiological Data
PatientBase is a flexible data tool set that you can easily manipulate to create custom epidemiological projections of key patient segments.
Physician & Payer Forum
Primary Market Research at a Multi-Client Price
Physician & Payer Forum includes direct feedback from high-volume-prescribing primary care physicians, viewpoints from the managed care sector and insight into the impact of events on specific markets.
Quantifying Lines of Therapy Through Patient-Level Claims Data
The Treatment Algorithms Insight Series delivers real value by examining physicians’ actual prescribing behavior as they initiate therapy and move through second- and third-line choices.
Invaluable Corporate and Commercial Analysis of the Biopharmaceutical Industry
Pharmaview offers all the insight you need to understand how each player in the biopharmaceutical industry functions. Financial information, individual company breakdown, therapeutic analysis and impact of major events are all contained in a subscription to Pharmaview.
Access Extensive Product Analogues to Understand Market Opportunity
The Analogue Tool is a dynamic, interactive web-based platform that allows users to search for product analogues based on a range of metrics.
Market Access Tracker
Timely Insights into a Fast-Changing Environment
Market access is increasingly critical to a drug’s commercial success, but it’s a challenge as payers are increasing prelaunch and post-marketing obstacles and the market access environment is in constant flux. Decision Resources’ Market Access Tracker service explains the challenges and opportunities to gaining favorable market access terms.
Turning Global Industry Trends into Actionable Insights
Spectrum is series of high-level, strategic reports from Decision Resources Group thought leaders, designed for corporate executives in the biopharma industry.
Niche Markets and Rare Diseases
Syndicated Market Research for Assessing Niche Pharmaceutical Markets
Providing vital insights into the competitive landscape and market opportunities for a given disease, helping companies save time and resources compared with expensive consulting engagements.
Decision Resources produces more than 150 reports each year. They span a broad array of subjects, ranging from specific diseases or research pathways to analysis of key issues facing the biopharmaceutical industry today.
Consulting & Advisory Services
Decision Resources Consulting group is dedicated to helping pharmaceutical, biotech and other healthcare companies develop true competitive advantage.
Epidemiology & Forecasting
Decision Resources offers the industry’s leading epidemiology and market forecasts for the world’s most significant diseases.